Empyema – Comprehensive Medical Guide

Overview

Empyema is an accumulation of pus within the pleural space—the thin fluid‑filled cavity that separates the lung from the chest wall. Unlike a simple pleural effusion, which is usually sterile fluid, empyema indicates an ongoing infection that can damage lung tissue and impair breathing.

Empyema most commonly follows bacterial pneumonia, lung abscess, or chest surgery, but it can also arise after chest trauma or in patients with immune suppression.

• Who it affects: Adults 50 years and older are at highest risk, although children can develop empyema, especially after severe pneumonia.
• Prevalence: In the United States, empyema accounts for ~10–15 % of all complicated parapneumonic effusions, translating to about 30,000–40,000 new cases each year [1]. Worldwide incidence varies with socioeconomic status and access to timely antibiotics.

Symptoms

Symptoms often evolve over days to weeks after the initial lung infection. The following list includes common and less‑common manifestations:

• Fever and chills – persistent >38 °C (100.4 °F) indicating systemic infection.
• Chest pain – usually sharp, pleuritic (worsens with deep breathing or coughing).
• Shortness of breath (dyspnea) – may be mild initially but can become severe as the pus occupies more space.
• Cough – often non‑productive, but can become productive with sputum that may be foul‑smelling.
• Fatigue and malaise – generalized feeling of illness.
• Night sweats – less common, may suggest a more indolent infection.
• Weight loss – especially in chronic empyema.
• Rapid heart rate (tachycardia) – a response to fever or hypoxia.
• Low oxygen saturation – measured by pulse oximetry; often <94 %.
• Chest wall tenderness – palpable pain over the affected side.
• Pleural friction rub – a creaking sound heard with a stethoscope, indicating inflamed pleura.

Causes and Risk Factors

Primary Causes

Empyema is almost always secondary to another infection or injury:

• Pneumonia – especially caused by Streptococcus pneumoniae, Staphylococcus aureus, or anaerobic bacteria from the oral flora.
• Lung abscess – a cavity filled with pus that can rupture into the pleural space.
• Thoracic surgery or chest tube placement – provides a direct route for bacteria.
• Traumatic injury – penetrating or blunt trauma that breaches the pleura.
• Tuberculosis (TB) – leads to a “tuberculous empyema,” often chronic.

Risk Factors

• Age > 50 years
• Chronic lung disease (COPD, bronchiectasis)
• Alcohol abuse – predisposes to aspiration pneumonia with anaerobes.
• Immunosuppression (HIV, chemotherapy, organ transplantation, long‑term steroids)
• Diabetes mellitus
• Malnutrition or low body‑mass index
• Recent upper‑respiratory infection without prompt antibiotic treatment
• Living in crowded or low‑resource settings where delayed care is common

Diagnosis

Accurate diagnosis requires a combination of clinical suspicion, imaging, and laboratory analysis.

Initial Assessment

• Full medical history and physical exam focusing on breath sounds, chest wall tenderness, and signs of systemic infection.
• Vital signs (temperature, heart rate, blood pressure, respiratory rate, oxygen saturation).

Imaging Studies

• Chest X‑ray – may show a fluid level, blunted costophrenic angle, or loculated collection.
• Chest CT scan (contrast‑enhanced) – gold standard for defining the size, location, and whether the fluid is loculated. CT also helps identify underlying pneumonia or lung abscess.
• Ultrasound – bedside tool to differentiate simple effusion from complex (septated) fluid and to guide thoracentesis.

Pleural Fluid Analysis (Thoracentesis)

A needle is inserted into the pleural space under imaging guidance. Fluid is sent for:

• Gram stain & culture – identifies causative bacteria; however, cultures are positive in only ~50‑60 % of cases.
• Purulence – visible pus is diagnostic.
• Biochemical tests – low pH (<7.2), low glucose (<60 mg/dL), high lactate dehydrogenase (LDH) > 1,000 U/L, and high protein suggest empyema.
• Polymerase‑chain reaction (PCR) – can detect atypical organisms (e.g., mycobacteria) when cultures are negative.

Additional Tests

• Complete blood count (CBC) – usually shows leukocytosis.
• Blood cultures – especially if sepsis is suspected.
• Serologic tests for HIV or tuberculosis if risk factors are present.

Treatment Options

Empyema is a medical emergency that requires prompt drainage and antimicrobial therapy. Management is staged according to the phase of the disease: exudative, fibrinopurulent, or organized (chronic).

Antibiotic Therapy

Empiric broad‑spectrum antibiotics should be started after cultures are obtained, then tailored based on results.

• First‑line regimens (US guidelines) – a beta‑lactam/beta‑lactamase inhibitor (e.g., ampicillin‑sulbactam) plus coverage for MRSA if risk factors exist (e.g., vancomycin or linezolid). For anaerobic infections, clindamycin or metronidazole can be added.
• Duration – usually 4–6 weeks, with the initial 2 weeks given intravenously, then oral step‑down if the patient improves and the pleural space is adequately drained.

Drainage Procedures

1. Chest tube thoracostomy (tube thoracostomy) – placement of a large‑bore drain (28–32 Fr) connected to suction. This is the first‑line mechanical method for most patients.
2. Image‑guided catheter drainage (pigtail catheter) – smaller caliber catheters (8–14 Fr) may be sufficient for non‑loculated collections.
3. Intrapleural fibrinolytic therapy – instillation of tissue‑type plasminogen activator (tPA) plus DNase (e.g., 10 mg tPA + 5 mg DNase twice daily for 3 days) improves drainage in fibrin‑septated empyema (MIST‑2 trial) [2].
4. Video‑assisted thoracoscopic surgery (VATS) – minimally invasive removal of thickened pleura (decortication) and thorough lavage. Indicated when medical drainage fails or in organized phase.
5. Open thoracotomy – reserved for very thick, chronic empyema or when VATS is not feasible.

Supportive Care

• Supplemental oxygen to maintain SpO₂ ≥ 94 %.
• Analgesia (e.g., acetaminophen, NSAIDs, or opioids) to allow deep breathing and coughing.
• Pulmonary physiotherapy – incentive spirometry, chest percussion, and early ambulation.
• Fluid and electrolyte management, especially in septic patients.

Lifestyle Adjustments During Treatment

• Smoking cessation – dramatically improves healing and reduces recurrence.
• Nutrition optimization – high‑protein diet or supplements to support immune function.
• Alcohol moderation – lowers risk of aspiration.

Living with Empyema

Even after the acute phase resolves, many patients face a period of recovery and monitoring.

Daily Management Tips

• Medication adherence – never skip antibiotics; finish the full prescribed course.
• Chest physiotherapy – perform incentive spirometry 5–10 breaths every hour while awake.
• Wound care – keep chest tube insertion sites clean and dry; watch for redness or drainage.
• Vaccinations – stay up‑to‑date on influenza and pneumococcal vaccines to prevent repeat pneumonia.
• Follow‑up imaging – repeat chest X‑ray or CT as ordered (usually 1–2 weeks after drainage) to confirm resolution.
• Activity – light activity is encouraged; avoid heavy lifting or strenuous exercise until cleared by your physician.

Psychosocial Aspects

Prolonged hospitalization and invasive procedures can be stressful. Seek support from counselors, patient‑support groups, or social workers. Many hospitals offer pulmonary rehabilitation programs that combine exercise with education.

Prevention

Because empyema almost always follows another infection, primary prevention focuses on reducing respiratory infections and optimizing early treatment.

• Vaccinations – annual flu shot and pneumococcal vaccine (PCV13 followed by PPSV23) for adults > 65 y or those with chronic lung disease.
• Prompt treatment of pneumonia – seek medical care for fever, cough, or chest pain; complete antibiotic courses.
• Good oral hygiene – reduces aspiration of anaerobic bacteria, especially in alcohol‑dependent or denture‑wearing patients.
• Avoid smoking and limit alcohol – both impair mucociliary clearance and immune function.
• Infection control in hospitals – proper sterile technique during thoracentesis, chest‑tube placement, and surgery.
• Manage chronic diseases – control diabetes, treat COPD, and address immune‑suppressing conditions with specialist care.

Complications

If empyema is not treated promptly or drainage is inadequate, several serious complications can develop:

• Septic shock – systemic infection leading to organ failure.
• Chronic fibrothorax – thick, scarred pleura that restricts lung expansion, causing persistent dyspnea.
• Bronchopleural fistula – abnormal connection between airway and pleural space, leading to persistent air leak.
• Respiratory failure – may require mechanical ventilation.
• Recurrence – especially if underlying risk factors (e.g., uncontrolled diabetes, ongoing aspiration) remain.
• Spread of infection – to mediastinum (mediastinitis) or bloodstream (bacteremia).

When to Seek Emergency Care

---

References

1. Center for Disease Control and Prevention. “Parapneumonic Effusions and Empyema.” Updated 2023. https://www.cdc.gov/pneumonia/empyrhea.html
2. Maskell NA, Davies R, Davies C, et al. "Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection." New England Journal of Medicine. 2019;380:110‑119. DOI:10.1056/NEJMoa1807615.
3. Mayo Clinic. “Empyema.” Accessed March 2024. https://www.mayoclinic.org/diseases-conditions/empyema
4. Cleveland Clinic. “Pleural Empyema: Diagnosis and Treatment.” 2023. https://my.clevelandclinic.org/health/diseases/16457-pleural-empyema
5. World Health Organization. “Tuberculosis and Empyema.” 2022. https://www.who.int/tb/knowledge/publications/empyema